共 50 条
- [24] CYP3A-Mediated Drug-Drug Interaction Potential and Excretion of Brentuximab Vedotin, an Antibody-Drug Conjugate, in Patients With CD30-Positive Hematologic Malignancies JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (08): : 866 - 877
- [25] Limitations of using a single postdose midazolam concentration to predict CYP3A-mediated drug interactions JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (06): : 671 - 680